These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1097 related items for PubMed ID: 15886816

  • 1. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M.
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
    Festuccia C, Muzi P, Millimaggi D, Biordi L, Gravina GL, Speca S, Angelucci A, Dolo V, Vicentini C, Bologna M.
    Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
    [Abstract] [Full Text] [Related]

  • 8. uPA and uPAR contribute to NK cell invasion through the extracellular matrix.
    Al-Atrash G, Kitson RP, Xue Y, Mazar AP, Kim MH, Goldfarb RH.
    Anticancer Res; 2001 Dec; 21(3B):1697-704. PubMed ID: 11497249
    [Abstract] [Full Text] [Related]

  • 9. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
    Guerrero J, Santibañez JF, González A, Martínez J.
    Exp Cell Res; 2004 Jan 01; 292(1):201-8. PubMed ID: 14720519
    [Abstract] [Full Text] [Related]

  • 10. The effect of EGFR-related tyrosine kinase activity inhibition on the growth and invasion mechanisms of prostate carcinoma cell lines.
    Unlü A, Leake RE.
    Int J Biol Markers; 2003 Jan 01; 18(2):139-46. PubMed ID: 12841683
    [Abstract] [Full Text] [Related]

  • 11. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
    Kargiotis O, Chetty C, Gogineni V, Gondi CS, Pulukuri SM, Kyritsis AP, Gujrati M, Klopfenstein JD, Dinh DH, Rao JS.
    Int J Oncol; 2008 Nov 01; 33(5):937-47. PubMed ID: 18949356
    [Abstract] [Full Text] [Related]

  • 12. c-jun-NH2JNK mediates invasive potential and EGFR activation by regulating the expression of HB-EGF in a urokinase-stimulated pathway.
    Cáceres M, Tobar N, Guerrero J, Smith PC, Martínez J.
    J Cell Biochem; 2008 Feb 15; 103(3):986-93. PubMed ID: 17654528
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cells.
    Shirk AJ, Kuver R.
    BMC Gastroenterol; 2005 Mar 31; 5():12. PubMed ID: 15801978
    [Abstract] [Full Text] [Related]

  • 14. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
    Li CC, Yao HT, Cheng FJ, Hsieh YH, Lu CY, Wu CC, Liu KL, Chang JW.
    Nutr Cancer; 2015 Mar 31; 67(5):771-82. PubMed ID: 25970488
    [Abstract] [Full Text] [Related]

  • 15. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.
    Kwon GT, Cho HJ, Chung WY, Park KK, Moon A, Park JH.
    J Nutr Biochem; 2009 Sep 31; 20(9):663-76. PubMed ID: 18824345
    [Abstract] [Full Text] [Related]

  • 16. The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells.
    Bonaccorsi L, Muratori M, Carloni V, Marchiani S, Formigli L, Forti G, Baldi E.
    Steroids; 2004 Aug 31; 69(8-9):549-52. PubMed ID: 15288768
    [Abstract] [Full Text] [Related]

  • 17. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 31; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 18. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 31; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 19. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R, Philip S, Mahabeleshwar GH, Bulbule A, Kundu GC.
    IUBMB Life; 2005 Jun 31; 57(6):441-7. PubMed ID: 16012053
    [Abstract] [Full Text] [Related]

  • 20. Urokinase induces receptor mediated brain tumor cell migration and invasion.
    MacDonald TJ, DeClerck YA, Laug WE.
    J Neurooncol; 1998 Dec 31; 40(3):215-26. PubMed ID: 10066093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.